Regression of cirrhosis with long-term tenofovir treatment

Affiliations

Comment

Vincent Wai-Sun Wong et al. Gastroenterology. 2013 Aug.

. 2013 Aug;145(2):481-2.

doi: 10.1053/j.gastro.2013.06.019. Epub 2013 Jun 20.

¹ Department of Medicine and Therapeutics and, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, The People's Republic of China.

No abstract available

Comment on

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Marcellin P, et al. Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10. Lancet. 2013. PMID: 23234725 Clinical Trial.